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precursors and become activated upon death induction.
Once activated, these proteases cleave a specific set of
substrate proteins that act as regulators of the apopto-
tic mechanisms and thus set the apoptotic program in
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ways is limited. Rather solid evidence implicates theHomozygous targeted disruption of the mouse Cas-
death-inducing activity of Fas/Apo1 in restricting thepase 8 (Casp8) gene was found to be lethal in utero.
immune response, mainly through self-destruction ofThe Caspase 8 null embryos exhibited impaired heart
lymphocytes and also in killing cells that express foreignmuscle development and congested accumulation of
antigens (reviewed in Nagata and Golstein, 1995). Othererythrocytes. Recoveryof hematopoieticcolony-form-
than this, however, there is little knowledge of the func-ing cells from the embryos was very low. In fibroblast
tional significance of the cell-killingactivity of the variousstrains derived from these embryos, the TNF recep-
receptors of the TNF/NGF family.tors, Fas/Apo1, and DR3 were able to activate the Jun
In this study, we attempted to gain more direct infor-N-terminal kinase and to trigger IkBa phosphorylation
mation about the role and functional significance of Cas-and degradation. They failed, however, to induce cell
pase 8 (Casp8) in the cell death±inducing activity of thedeath, while doing so effectively in wild-type fibro-
receptors of the TNF/NGF family by targeted disruptionblasts. These findings indicate that Caspase 8 plays
of the mouse Caspase 8 (Casp8) gene.a necessary and nonredundant role in death induction
by several receptors of the TNF/NGF family and serves
Resultsa vital role in embryonal development.
The Mouse Caspase 8 cDNA and GeneIntroduction
Using the human CASP8 cDNA as a probe, we cloned
the corresponding mouse cDNA, which we then usedProgrammed cell death in metazoans involves a crucial
to clone the mouse Casp8 genomic region. Detailedrole for the caspases, members of a cysteine protease
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exons II and III, the second DED; exon IV, the intermedi-9 Present address: Centre National de Sequencage, BP 191, 2 rue
Gaston Cremieux, 91000 Evry, France. ate region between the DEDs and the protease region;
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Figure 1. The Mouse Caspase 8 cDNA, Its Exon Structure, and Its Embryonic Expression in Midgestation
(A) Collinear amino acid sequence alignment of the mouse and human Caspase 8 gene. The residues are numbered to the right of each
sequence. Dashes indicate gaps in the sequence to allow optimal alignment. The DED modules are shown in dark shading. The protease
homology region is shown in light shading. Identical amino acids are shown in boxes. Within the region of protease homology, the residues
putatively involved in catalysis are shown in dark shading and marked by closed circles below the alignment. The residues constituting the
binding pocket for the carboxylate side chain of P1 Asp are less heavily shaded and are marked by open circles. The potential sites of
cleavage are darkly shaded.
(B) Splice junctions of the mouse Caspase 8 (Casp8) gene. Bases matching the splicing consensus sequence are noted in bold. The polyadenyla-
tion signal is underlined and the polyadenylation site is shaded.
(C) Analysis of the expression of Casp8 in a wild-type embryo at 10.5 dpc. Whole-mount mRNA in situ hybridization. Abbreviations: ba,
bronchial arches; flb, forelimb bud; hlb, hindlimb bud; ht, heart. Arrow, area of the mid-hind brain junction. Arrowhead, region of the dorsal
mesentery.
exons V through VIII, the protease region; and exon VIII, The mouse chromosomal location of the Casp8 locus
was determined by interspecific backcross analysisalso encoding the 39 UTR (Figures 1A, 1B, and 2B).
The boundaries between exons IV, V, and VI roughly using the 94 progeny in the Jackson BSS cross. Poly-
morphisms were detected upon PCR amplification ofcorresponded to those of ªblocksº 1, 2, and 3, parts of
the Casp8 molecule that occur in differentsplice variants C57BL/6J and M.spretus genomic DNAs. Linkage analy-
sis revealed that the mouse Casp8 gene maps to theof the human protein in various combinations (Boldin et
al., 1996). The 39 UTR contained a noncanonical polyad- proximal region of chromosome 1 [Centromere-D1Mit4-
17.02 6 3.88 cM-Inpp1-1.06 6 1.06 cM-Casp8, Cd152-enylation signal (AATATA) located 14 bp upstream of
the adenylation site, followed by a stretch of GT-rich 4.25 6 2.08 cM-Crygb-3.19 6 1.81 cM-D1Mit7].
The human CASPASE 8 (CASP8), CASPASE 10sequence, and ending with a T7 stretch (Figure 1B).
To characterize the 59 region of the Casp8 gene, we (CASP10), and caspase homolog (CASH) genes have
been localized to chromosome 2, band q33±34, telo-isolated a P1 mouse genomic clone of about 60±70 kb
that hybridized with the identified genomic sequence. meric to the STS marker D2S116 (Fernandes-Alnemri et
al., 1996; Han et al., 1997; Rasper et al., 1998; V. M. B.This clone contained the region between exons I and VI
and, about 15 kb upstream of exon I, two additional and E. E. V., unpublished data). This region is homolo-
gous to that found for the mouse Casp8 gene. It is con-exons corresponding to two alternative 59 UTRs of the
Casp8 cDNA. In addition, about 30 kb further upstream sistent with the location of inositol polyphosphate-1-phos-
phatase (INPP1), cytotoxic T-lymphocyte-associatedit contained an exon corresponding to the 39 end of the
cDNA of CASHa, a proteolytically inactive homolog of protein 4 (CTLA4), and gamma B crystallin (CRYGB), the
human homologs of Inpp1, Cd152, and Crygb, respec-Casp8 and Casp10 (also having several other names,
such as cFLIP and Casper), which apparently acts as tively, which were found adjacent to mouse Casp8.
Comparison with the location of several different knowna modulator of death initiation by Casp8 (reviewed in
Wallach, 1997) (Figure 2A). human EST and STS markers indicated that the human
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Figure 2. Targeting the Caspase 8 Gene
(A) Analysis of the mouse Casp8 genomic region. Aligned contig and partial restriction map of seven phage clones and a P1 clone encompassing
the mouse Casp8 genomic locus. The bottom line represents the final contig, based on alignment of the indicated clones. Boxes correspond
to the genomic regions containing the 39 end exon of CASHa (light shading), and the two 59 untranslated exons of Casp8 (dark shading).
Restriction sites are marked by vertical lines. ªV,º ªI,º ªB,º and ªNº correspond to EcoRV, EcoRI, BamHI, and NotI, respectively. The region
marked by a vertical arrow upstream of a NotI site contains additional unresolved restriction nuclease recognition sites. The orientations of
the CASH and Caspase 8 genes are marked by horizontal arrows.
(B) Structure of a 32.5 kb region in the mouse Casp8 gene encompassing the coding region and 39 UTR in the gene. The exons, deduced by
comparison with the cDNA sequence, are denoted by black boxes. The positions of the endogenous and introduced restriction sites are
marked by vertical lines (ªRV,º ªP,º ªX,º ªB,º and ªRIº correspond to EcoRV, PvuII, XbaI, BamHI, and EcoRI restriction sites, respectively; only
the restriction sites essential for the analysis are shown). The positions of the 59 and 39 external probes applied for Southern blot analysis of
the recombination are underlined.
(C) The targeting construct designed to replace most of the first exon and the whole second exon with a floxed neor cassette. The positions
of the loxP sites flanking the neor cassette are designated by open triangles.
(D) Structure of the mutated region in the Casp8 gene.
(E) Southern blot analysis of the recombination in the Casp8 gene. Analysis of XbaI-digested DNA derived from 10.5 dpc embryos obtained
by crossing heterozygotic mice. (EI) Mice whose DNA contains the neor cassette. (EII) Mice after excision of the neor cassette. DNA was
digested with XbaI, fractionated on 0.8% agarose gel, blotted onto a nylon membrane, and hybridized with a 59 probe.
(F) Whole view of a 12.5 dpc Casp82/2 homozygous mutant embryo.
CASH gene is located centromerically to CASP8, and in the heart (especially in the primitive ventricle), the
surface ectoderm of the fore- and hindlimb buds, thethat the 59 ends of both genes (as well as of the CASP10
gene, which is located between them) are oriented to- branchial arches, and the area of the mid±hind brain
junction (see arrow in Figure 1C) as well as in the regionward the centromere (V. M. B., unpublished data). Pre-
sumably, the mouse Casp8 and CASH genes are simi- of the dorsal mesentery (Figure 1C, arrowhead).
larly oriented.
Targeted Disruption of the Caspase 8 Gene
Results in a Lethal Embryonic PhenotypeTranscription Pattern of Caspase 8 in the
Midgestation Mouse Embryo Casp8 binds toMORT1/FADD through its twoN-terminal
DED motifs (Boldin et al., 1996; Muzio et al., 1996). ToBoth whole-mount in situ hybridization (Figure 1C) and
radioactive histological in situ hybridization (data not abolish signaling to death through this caspase, we
transfected R1 embryonic stem (ES) cells with a tar-shown) at gestational ages between 9.5 and 12.5 days
postcoitum (dpc) revealed widespread distribution of geting vector allowing replacement of exons I and II,
which encode these motifs, with a neomycin resistanceCasp8 transcripts. Elevated signals could be detected
Immunity
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Figure 3. Histological Study of the Caspase
82/2 Embryos
Liver of (A) wild-type and (B) mutant
(Casp82/2) embryos at 11.5 dpc. (C) Lung of
a mutant embryo at 10.5 dpc. (D) Intersomitic
blood vessel of mutant embryo at 11.5 dpc.
(E) Eye of mutant embryo at 12.5 dpc (note
hyperemia in the lens capsule). Heart of (F)
wild-type and (G) mutant embryos at 11.5
dpc. Heart of (H) wild-type and (I) mutant em-
bryos (high magnification) at 12.5 dpc. Abbre-
viations: at, atrium of the heart; br, bronchus;
ca, camera (common ventricle) of the heart;
ec, erythrocytes; hc, presumptive hepato-
cytes; hm, presumptive heart muscle cells;
hp, hematopoietic precursors; lu, lung; rc,
round cells (lymphocytes?); tr, trabeculae of
the heart ventricule. Arrows in (D), endothelial
cells; arrowheads in (e), capsula lentis. Scale
bars: (A and B), 40 mm; (C), 100 mm; (D), 20
mm; (E), 200 mm; (F and G), 100 mm; (H and
I), 40 mm.
(neor) cassette (Figures 2B, 2C, and 2D). Of 186 recombi- mutant embryos were somewhat smaller than their wild-
type littermates, but they were normally shaped andnant ES clones examined, 2 were positive for homolo-
gous recombination. Germline competent chimeras were formed according to their gestational age. Histological
examination revealed extensive erythrocytosis in thegenerated by aggregation of the recombinant ES cells
with morula-stageembryos, and progeny from heterozy- liver at day 10.5±13.5 dpc. Most of this organ was occu-
pied by fully formed embryonic erythrocytes. Normalgous parents (Casp81/2) were examined.
Although theheterozygous mice appeared phenotypi- embryonic liver tissue, with its characteristic early he-
matopoietic elements, and early liver cells were visiblecally normal, no homozygous (Casp82/2) mice could be
detected in their intercross, whereas the Casp81/2 and only in the cortical area (compare Figures 3A and 3B).
Hyperemia similar to that seen in the liver was observedCasp81/1 genotypes were represented in a ratio of 2 to
1, indicating that the homozygous disruption of Casp8 in most major blood vessels and in many organs (for
example, the lung [Figure 3C]); it was also seen in theleads to prenatal death. Southern analysis of the geno-
types of embryos collected between 9.5 and 11.5 dpc intersomitic (Figure 3D) and interprevertebral blood ves-
sels, mesenchymal spaces, the retina, and under the(Figure 2E) disclosed normal Mendelian segregation ra-
tios. Until day 10.5, no gross morphological abnormali- capsule of the lens (Figure 3E). Examination at high
magnification revealed that the erythrocytes were con-ties could be detected. At day 11.5, however, 40% of the
Casp82/2 embryos displayed the abnormal phenotype tained in larger and smaller blood vessel areas (Figure
3D), suggesting hyperemia and/or congestion ratherdescribed below, and at day 12.5 almost all Casp82/2
embryos examined had this phenotype and some were than outright bleeding.
Detailed histological observation also revealed thatfound dead or close to death.
The most salient feature of the abnormal phenotype the heart had developmental abnormalities. Although
the heart was not appreciably larger than normal, theof the Casp82/2 mutant was marked hyperemia in the
abdominal area (Figure 2F). In most mutant embryos developing ventricular musculature was thin and in
some cases not different from early mesenchyme. Thethis was accompanied by hyperemia in the superficial
capillaries and other blood vessels, mainly in the umbili- trabeculae were thin and disorganized (compare Figures
3F and 3G as well as Figures 3H and 3I).cal and trunk area, including those in the intersomitic
and interdigital blood vessels and to a lesser degree the To further investigate the nature of the hyperemia, we
assessed the numbers of hematopoietic precursors inface, head, and even the lens of the eye (Figure 3). Most
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Figure 4. Noncytocidal Effects of the TNF Receptors, Fas/Apo1, and DR3 in Wild-Type and Caspase 82/2 Mice
(A) Time course of c-Jun phosphorylation. (B) Time course of IkBa phosphorylation and degradation. Cells were stimulated with 2000 U/ml
of human TNFa or monoclonal anti-Fas or (in the case of cells transfected with the CD120a-DR3 chimera) anti-CD120a antibodies for the
indicated time periods, or they were left unstimulated (c). They were then collected, lysed, and either subjected to immunoprecipitation by
antibodies raised against JNK1 followed by in vitro kinase reaction using recombinant GST-c-Jun as substrate or analysed by Western blotting
using phosphospecific anti-IkBa or phosphorylation state±independent anti-IkBa antibodies.
the normal and mutant 11.5 dpc embryos. Whereas the receptor (CD120a) and the intracellular domain of DR3,
a DD-containing receptor of the TNF/NGF family thatcells of normal embryos yielded greater than 500 colo-
nies (mostly myeloid) per input of 5 3 104 cells in the in induces cell death by a mechanism that seems closely
related to that of CD120a (Chinnaiyan et al., 1996; Kitsonvitro test, the same cell input yielded fewer than 10
colonies on average in the mutants (see Experimental et al., 1996; Marsters et al., 1996a; Bodmer et al., 1997).
Gene activation by TNF and DR3 involves stimulationProcedures). Disruption of the Casp8 gene thus appears
to result in a dramatic primary or secondary depletion of the transcription factors NF-kB and AP1 through pro-
tein kinase cascades that lead to phosphorylation of theof the hematopoietic precursor pool.
The recombination event by which Casp8 was dis- AP1-component Jun (reviewed in Kyriakis and Avruch,
1996) and the NF-kB inhibitory protein IkB (reviewed inrupted involved the introduction of a neor gene flanked
by two loxP recombination target sequences into the Stancovski and Baltimore, 1997). Activation of Fas/Apo1
also leads to enhanced phosphorylation of Jun (Latinismouse genome (see Experimental Procedures). To con-
firm that theobserved phenotype resulted from deficient and Koretzky, 1996; Goillot et al., 1997; Lenczowski et
al., 1997; Yang et al., 1997). As shown in Figure 4, theseCasp8 expression and not from distortion of the expres-
sion patterns of other genes by the neor gene or its effects could be induced in the Casp82/2 fibroblasts just
as effectively as in the wild-type cells. In cells derivedcontrol elements, we excised the loxP-flanked insert by
mating mice heterozygous for the recombination with from both sources, treatment with TNF, as well as liga-
tion of Fas/Apo1 or the CD120a-DR3 chimera, inducedPGK-Cremat (Lallemand et al., 1998) transgenic mice (Fig-
ure 2E, II). Comparison of neo1 and neo2 mutants re- increased Jun N-terminal kinase activity within 5 min of
stimulation (Figure 4A); in addition, TNF treatment orvealed no differences in their gross phenotype or in the
kinetics of their prenatal death. CD120a-DR3 ligation induced phosphorylation of IkBa,
which was promptly followed by IkBa degradation (Fig-To confirm that the recombination effect was re-
stricted to Casp8, we evaluated the embryonic expres- ure 4B).
sion of CASH, a gene located upstream of Casp8 (Figure
2A). The expression of CASH, which could be discerned Cultured Fibroblasts Derived from the Caspase 82/2
both in the embryos and in the ES cells, seemed unaf- Mice Are Resistant to Death Induction by the TNF
fected by the homologous recombination, while Casp8 Receptors, Fas/Apo1, and DR3 but Are
expression was abolished (data not shown). Sensitive to Death-Inducing Agents
that Act from within the Cell
Wild-type (Casp81/1) cells were killed by human TNFCultured Fibroblasts Derived from the Caspase 82/2
Mice Respond Normally to Noncytocidal when it was applied to these cells in the presence of
the protein-synthesis blocker cycloheximide. They wereEffects of the TNF Receptors,
Fas/Apo1, and DR3 also killed by antibody cross-linking of Fas/Apo1. In
addition, the wild-type cells expressing the CD120a-To assess the functional consequences of the Casp8
mutation at the levelof the individual cell,we established DR3 chimera were killed by cross-linking these chimeric
molecules using antibodies to human CD120a. In con-continuous fibroblast strains from wild-type and Casp82/2
embryos at 10.5 dpc. From each of the strains we also trast, cells derived from the Casp82/2 embryos were
completely resistant to death induction by these agentsderived cell lines expressing a chimeric receptor com-
prised of the extracellular domain of the human p55 TNF (Figure 5). They wereequally resistant to killing bymouse
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Figure 5. Caspase 8 Is Required for Death
Induction by Fas/Apo1, TNF, or DR3 but Not
for Its Induction by UV Irradiation, Etoposide,
Ceramide, Staurosporine, Serum Starvation,
or VSV
The figure shows the proportions of cells
that remained viable following incubation of
wild-type (filled squares and triangles) and
Casp82/2 fibroblasts (open circles and dia-
monds) with the indicated reagents. Means 6
SD of duplicate representative examples
from a series of at least seven experiments
are shown.
TNF (not shown). The Casp82/2 cells could, however, the data suggesting otherwise are based on their involve-
ment in death induction by other receptors, which actbe killed by various other death-inducing agents includ-
similarly to those utilizing Casp8 in their death-inducinging UV irradiation; the protein kinase inhibitor stauro-
function. Tests employing overexpression of dominantsporine; the topoisomerase inhibitor etoposide, C6-cer-
negative mutants of signaling molecules to assess theamide, which is believed to act as an intracellular
involvement of such molecules in signaling are prone tomediator of some signaling pathways for cell death;
such misinterpretation, as illustrated by the conflictingand the cytopathic virus vesicular stomatitis virus (VSV).
reports on the mechanisms of death induction by TRAIL/They were also killed by serum deprivation (Figure 5).
Apo2-L, a ligand related to TNF. Some of these studies
suggested that the receptors triggered by TRAIL/Apo2-L
Discussion employ MORT1/FADD and Casp8 in death induction
The resistance of Casp82/2 fibroblasts to death induc- (Chaudhary et al., 1997; Schneider et al., 1997; Walczak
tion by several receptors of the TNF/NGF family, despite et al., 1997; Wajant et al., 1998), while others pointed to
their normal responses to other, noncytocidal effects of the involvement of Casp10 and some adapter protein(s)
the same receptors, implies that Casp8 plays a central other than MORT1/FADD (Marsters et al., 1996b; Pan et
and nonredundant role in the death-induction mecha- al., 1997; Yeh et al., 1998). Unfortunately, the fibroblast
nism. This finding may appear to be at variance with lines established in thepresent study showed little death
studies suggesting that death inductionby the receptors in response to TRAIL/Apo2-L, precluding their use for
can also occur through other signaling pathways, assessing the involvement of Casp8 in death induction
namely, activation of Casp10 and Casp2 in a manner by TRAIL/Apo2-L.
similar to the activation of Casp8 (reviewed in Villa et While pointing to a crucial role for Casp8 in death
al., 1997) and activation of the Jun N-terminal kinase induction by receptors of the TNF family, our data indi-
through the adapter protein Daxx (Yang et al., 1997). cate that this caspase is not essential in death induction
This apparent discrepancy could be accounted for in a by agents like etoposide or staurosporine. These agents
number of possible ways: (1) although these otherdeath- employ caspases in their death-inducing effects (Jacob-
inducing pathways might contribute to death induction, sen et al., 1996; Martins et al., 1997; Bossy-Wetzel et al.,
their contribution perhaps depends on a permissive role 1998), yet they apparently function through activation of
of Casp8; (2) these alternative pathways might act in a intracellular mechanisms such as those triggered by
cell-type-specific manner, having little involvement in cytochrome c upon its release from damaged mitochon-
death induction in fibroblasts, yet important roles in dria to the cytosol (Li et al., 1997).
other cells; or (3) these pathways might not mediate Our findings also indicate that Casp8 is not involved
in the induction of phosphorylation and degradation ofdeath induction by the TNF receptors or Fas/Apo1, and
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IkBa, nor in the induction of Jun N-terminal kinase acti- formation should fully clarify whether or not defective
blood vessel formation contributes to the phenotype.vation by the TNF receptors, Fas/Apo1, or DR3. Studies
have indeed delineated caspase-independent signaling The extensive hyperemia could also have originated
from a hematopoietic defect. Some kind of hematopoi-pathways through which these receptors can stimulate
the protein kinases involved in these two effects (see etic abnormality whose nature has yet to be clarified is
indeed indicated by the dramatic decrease of hemato-Ting et al., 1996; Yeh et al., 1997; Kelliher et al., 1998,
and references cited therein). Nevertheless, there is also poietic precursors in the Casp82/2 mice. We cannot,
however, exclude the possibility that this hematopoieticevidence suggesting that Jun N-terminal kinase activa-
tion by Fas/Apo1 can occur in a way that does depend defect was secondary to poor circulation, nor can we
exclude the possibility that some additional, less easilyon caspase activation (Chen et al., 1996; Lenczowski
et al., 1997; Roulston et al., 1998). Again, while clearly discernible consequence(s) of the disruption of the
MORT1/FADD or Casp8 genes contributed to the deathexcluded from operating in fibroblasts, such a Casp8-
dependent signaling pathway may well be found to act of the embryos. Assessment of the effect of MORT1/
FADD disruption on the development of lymphocytesin other cells.
The in vivo consequences of the targeted disruption indicated that this adapter protein contributes not only
to the regulation of death of these cells, but also to theof the Casp8 gene are quite different from those ob-
served for knockout mutations of ligands or receptors induction of their growth (Zhang et al., 1998). Likewise,
it may well be that the lethal effect of MORT1/FADD orknown to employ Casp8 in their death-inducing path-
ways. Disruption of the genes of the TNF receptor Fas/ Casp8 disruption on these embryos results not from
insufficient death induction, but from deficient induc-Apo1 or its ligands had pronounced effects on immune
functions that operate in the adult. Yet, in contrast to tion of some other effect (perhaps growth stimulation)
through the MORT1/FADD±Casp8 signaling pathway.the lethal prenatal effect of Casp8 disruption, ablation
of the expression of these ligands or receptors had al- Our understanding of the in vivo significance of cell
death lags significantly behind our knowledge of themost no effect on the development of the mice, the only
exception being defective Peyer's patch organogenesis mechanisms involved in this process. The current state
of knowledge of the cell death±inducing function of TNFin mice with targeted disruption of the p55 TNF receptor
(CD120a) (reviewed in Gruss and Dower, 1995; Matsu- is a pertinent example. We have known for more than
30 years that TNFa and LTa (TNFb) can cause death ofmoto et al., 1997). This apparent discrepancy implies
that, apart from signaling for the effects of the TNF cells. Yet, while many other activities of these pleiotropic
cytokines have been well placed in a physiological con-receptors, Fas/Apo1, and DR3, Casp8 also mediates
signaling by other stimuli that play vital roles in em- text, there is not yet even the slightest hint of the types
of in vivo situations in which the direct cytocidal effectbryogenesis. One candidate for such a stimulus is the
ligand for DR3 (Marsters et al., 1998), a receptor shown of TNF is manifested. This function of TNF, like most
other known activities of the TNF ligand family, presum-conclusively in this study to involve Casp8 in its signaling
for death. ably contributes to immune defense, but the way in
which it does so is unknown. The targeted disruptionThe Casp82/2 embryonic phenotype is characterized
by two salient features: impaired heart muscle develop- approach provides a valuable tool for bridging this gap
between molecular and physiological understanding, asment and congested accumulation of erythrocytes.
These features resemble the recently reported pheno- it allows genes found to participate in the death process
to be used as molecular probes for assessing the in vivotype of mice with targeted disruption of the MORT1/
FADD gene (Yeh et al., 1998; Zhang et al., 1998). MORT1/ occurrence and functional consequences of the death
process. The obligatory and specific role of Casp8 inFADD2/2 embryos died at about the same age as the
Casp8-deficient mice. Moreover, like the Casp8-defi- death induction by receptors of the TNF/NGF family
endows this molecule with particular value as such acient embryos, they exhibited impaired heart muscle
development and congested accumulation of erythro- probe. This value could not be fully exploited in the
present study, since the prenatal death of the knockoutcytes. Conceivably, the death of the MORT1/FADD2/2
embryos can be accounted for by the failure to activate embryos precluded analysis of the involvement of the
Casp8 enzyme in functions manifested in the adult mice.Casp8.
The mechanism underlying the midgestation lethal Restricting the disruption of the Casp8 gene to specific
Casp82/2 phenotype remains to be clarified. Congestion time periods during development or specific tissues
and edema frequently accompany heart failure. In our (e.g., by creating mice chimeric for the recombination or
case, however, no generalized edema was observed. by conditional disruption of the gene in a developmental
Moreover, a similar failure of midgestation heart devel- stage-specific or cell lineage±specific manner) should
opment in the targeted mutation of neuregulin was not allow further progress both in elucidating the role of this
accompanied by congestion or hyperemia (Meyer and protein in embryonic development and in studying its
Birchmeier, 1995). Defects such as those observedin the function in the adult mouse.
Casp82/2 mice could be due to abnormal angiogenesis.
However, despite detailed examination, we could not
Experimental Proceduresdiscern any defects in the small or large blood vessels
of the mutants. Indeed, the MORT1/FADD2/2 embryos Isolation of the Mouse Caspase 8 cDNA
were found to exhibit normal expression of flk-1, a major The mouse Casp8 cDNA was isolated from a lgt11 oligo(dT)-primed
regulator of early angiogenesis (Yeh et al., 1998). Thor- library derived from LPS-treated BAM3 mouse macrophage cells
(kindly provided by S. Nagata; Watanabe et al., 1992) by screeningough investigation of additional markers of blood vessel
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with a fragment of the human CASP8 cDNA. The inserts from the Chimeric mice were produced by aggregation as described (Nagy
and Rossant, 1993). Germline transmission in mice generated bypositive phages were subcloned into pBluescript vector and se-
quenced by the dideoxy chain-termination method. Sequence align- mating chimeric males with MF1 females was detected by coat color
and reconfirmed by Southern analysis of tail DNA.ment of the mouse and human Casp8 cDNAs was performed, and
their homology was evaluated using the alignment program in Gene- In a fraction of the population, the ªfloxedº neor cassette was
deleted by mating Casp81/2 mice with the early ªdeleterº transgenicAssist 1.1 b4 (Perkin-Elmer, Applied Biosystem Division).
mouse strain Cremat (Lallemand et al., 1998).
Cloning of the Mouse Caspase 8 Gene and Adjacent Regions
A 129/Sv mouse genomic library (Stratagene) was screened with a
Whole-Mount mRNA In Situ Hybridization
mouse Casp8 cDNA probe. Of 1 million clones screened, 7 overlap- and Histological Analysis
ping clones encompassing the full coding and the 39 UTR regions Whole-mount mRNA in situ hybridization in 10.5 dpc embryos was
in the Casp8 gene were isolated. Their inserts were subcloned into performed as described (Conlon and Herrmann, 1992) using single-
the pBluescript vector using appropriate restriction enzymes and strand digoxigenin-UTP-labeled mouse Casp8 sense and antisense
sequenced in both directions with dye terminators on ABI377. The RNA probes. Radioactive in situ hybridization was as described
Sequencher program (version 3.0 for Macintosh) was used for analy- previously (Orr-Urtreger et al., 1993). Histological investigations
sis of the sequences and for final assembly of the sequence contig. were in Paraplast sections (7 mm) and H-E staining.
To define the exon±intron boundaries of the Casp8 gene, its cDNA
sequence was compared with that of the genomic contig using
the alignment program in GeneAssist 1.1 b4 (Perkin-Elmer, Applied In Vitro Hematopoietic Colony Assay
Biosystem Division). To obtain genomic clones that contain the 59 Semisolid cultures were established in order to determine the levels
UTR region, we screened a mouse genomic library in P1 (MP1Mouse of hematopoietic progenitors in wild-type and Casp82/2 embryos.
P1 library number 703, Resource Center, Berlin-Charlottenburg, Yolk sacs and total embryos were dissected, mechanically dis-
Germany) using a fragment at the 59 end of the sequence isolated rupted, and filtered through 15 mm nylon mesh. For determination
from the phage library as a probe (the ª59 probeº in Figure 2B). of the genotype of the embryos, DNA was isolated from embryonic
Further restriction nucleotide mapping of this clone and analysis of limbs and subjected to Southern analysis as described above. Cell
its structure were done by Southern DNA hybridization, using spe- viability was determined by trypan blue staining. Samples of 5 3
cific oligonucleotides of T7, SP6, CASHa, or Casp8 cDNA as probes. 104 viable cells were plated in RPMI medium containing 0.9% meth-
ylcellulose (Sigma, St. Louis, MO), 30% fetal calf serum (FCS), 5 3
1025 M b-mercaptoethanol, 50 ng/ml SCF, 100 ng/ml FLT3 ligandGenetic Mapping of the Caspase 8 Gene
(Immunex, Seattle, WA), 6 U/ml erythropoietin (EPO, Orto Bio Tech,The chromosomal location of the mouse Casp8 gene was deter-
Don Mills, ON, Canada), and murine IL-3 (culture medium of the IL-mined by linkage analysis with the BSS Backcross DNA Panel (Jack-
3-producing cell line X63/O [kindly provided by Dr. M. Oren] appliedson Laboratory, Bar Harbor, ME). The panel consists of 94 geno-
at a dilution of 1:100) in 6 CM culture dishes. The cultures weretyped progeny derived from a (C57BL/6JEi 3 SPRET/Ei)F1 3
incubated at 378C in a humidified atmosphere containing 5% CO2SPRET/Ei backcross (Jackson BSS) (Rowe et al., 1994). The allele
and scored 7 days later for myeloid, erythroid, mixed, and blastpattern of Casp8 was compared using Map Manager (Manly, 1993)
colonies identified according to morphological criteria. More thanto those of the approximately 3200 previously mapped loci in the
ten embryos of each kind, obtained from seven pregnancies, wereJackson BSS cross, and the exact position determined by minimiz-
examined.ing double crossovers (http:www.jax.org/resources/documents/
cmdata/).
For allele detection, Casp8 PCR primers (59-GGTGATCTGAGTTT
Establishment of Embryonic Fibroblast Cell StrainsGATCTCTGGAACACAT-39 and 59-CCCGTGACTCACTGTCTTGTTC
Fibroblasts derived from 10.5 dpc embryos by trypsinization (Todaro
TCTT-39) were used to amplify mouse genomic DNA purified from
and Green, 1963) were grown in Dulbecco's modified Eagle's mini-
C57BL/6JEi and SPRET/Ei inbred strains (by denaturation for 45 s
mal essential medium (DMEM), supplemented with 10% FCS,
at 948C, annealing for 1 min at 578C, extension for 50 s at 728C,
nonessential amino acids, 100 U/ml penicillin, and 100 mg/ml strep-
33 cycles, followed by further extension for 5 min at 728C). PCR
tomycin.Cell strains from individual embryos of mice whosegenome
amplification of C57BL/6JEi DNA identified a 396 bp fragment and
did not contain the neor cassette were established by their transfor-
amplification of SPRET/EiDNA identified a 310bp fragment resolved
mation with an SV40 T antigen±expressing retroviral vector (Almazan
on a 2% agarose gel. In the BSS cross, the presence or absence
and McKay, 1992).
of the 396 bp C57BL/6JEi-specific fragment was followed in the
To assess the effect of DR3 signaling in theT antigen±transformed
backcross mice. Homology data were retrieved from the Human
fibroblasts, a cDNA encoding a CD120a-DR3 chimera, produced byGenome Database (GDB; http://www.gdb.org/) and the Mouse Ge-
fusion of the extracellular domain of human CD120a (amino acidsnome Database (MGD; http://www.informatics.jax.org/).
1±168) with the transmembrane and intracellular domains of human
DR3 (amino acids 197±417), was subcloned into the pBabe-Hygro
Construction of a Caspase 8 Targeting Vector retroviral vector (Morgenstern and Land, 1990) and transfected into
and Production of Knockout Mice the BOSC 23 retroviral packaging line (Pear et al., 1993). Superna-
A targeting vector was constructed in the pPNT vector (Samuel tants of these cells were applied to the T antigen±transformed fibro-
Lunenfeld Research Institute, Toronto, Canada) by replacing a 4.8 blasts, followed by selection for hygromycin-resistant colonies, as
kb fragment of Casp8 encompassing the first two coding exons described (Morgenstern and Land, 1990). All tests of DR3 function
with a PGK-neor-polyadenylate (poly A) cassette bordered by loxP were performed using the CD120a-DR3 chimera±expressing cells
sites (derived from the pLoxpNeo vector, Samuel Lunenfeld Re-
search Institute, Toronto, Canada). The construct contained two
DNA stretches derived from the 129 mouse genome: a 2.4 kb frag- In Vitro JNK1 Assay
Cells (4 3 105) were seeded into 6 cm plates and, after overnightment placed 59 of the neor cassette and a 3.6 kb fragment, encom-
passing exons III, IV, and V, placed 39 of the neor cassette. The neor incubation, were treated with human TNFa (2000 U/ml; Genentech,
South San Francisco, CA), the Jo2 anti-mouse Fas/Apo1 antibodygene was introduced in the opposite transcriptional orientation to
Casp8 (Figure 2C). (2 mg/ml; Pharmingen, San Diego, CA), or (when using cells express-
ing the CD120a-DR3 chimera) monclonal antibodies against the hu-R1 embryonic stem (ES) cells (Nagy and Rossant, 1993) were
transfected with the targeting vector linearized with NotI. Recombi- man CD120a (20 mg/ml of the antibodies produced by clones 18
and 20 [Engelmann et al., 1990] at a 1 to 1 ratio) for the indicatednant ES cellclones were selected by the positive-negative technique
(Mansour et al., 1988). The genotype of positively selected clones time periods. They were then lysed, JNK1 was immunoprecipitated
from the cell lysate using the anti-JNK1 C-17 polyclonal antibodywas evaluated by Southern analysis using genomic DNA probes
from regions upstream of the 59 arm and downstream of the 39 arm (Santa Cruz Biotechnology, CA), and in vitro kinase reaction using
purified glutathione S-transferase GST-c-Jun (5±89) as substrateof the targeting construct (Figure 2B).
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was performed as described (Kerkhoff and Rapp, 1997). 32P incorpo- Involvement of MACH, a novel MORT1/FADD-interacting protease,
in Fas/APO1- and TNF receptor-induced celldeath. Cell 85, 803±815.ration into the GST-c-Jun (5±89) was determined by SDS-PAGE
analysis followed by autoradiography. Bossy-Wetzel, E., Newmeyer, D.D., and Green, D.R. (1998). Mito-
chondrial cytochrome c release in apoptosis occurs upstream of
Western Blot Analysis of TNF- and DR3-Induced IkBa DEVD-specific caspase activation and independently of mitochon-
Phosphorylation and Degradation drial transmembrane depolarization. EMBO J. 17, 37±49.
Cells were seeded and treated with human TNFa or anti-human Chaudhary, P.M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J.,
CD120a for the indicated periods as described above for the in vitro and Hood, L. (1997). Death receptor 5, a new member of the TNFR
JNK1 assay. The cells were then lysed in SDS-PAGE lysis buffer family, and DR4 induce FADD dependent apoptosis and activate
and analyzedby SDS-PAGEfollowed by Western blot analysis, using the NF kB pathway. Immunity 7, 821±830.
phosphospecific anti-IkBa (Ser32) or phosphorylation state±inde- Chen, Y.R., Wang, X., Templeton, D., Davis, R.J., and Tan, T.H.
pendent anti-IkBa antibodies (New England Biolabs, Beverly, MA) (1996). The role of c-Jun N-terminal kinase (JNK) in apoptosis in-
and the ECL kit (Amersham, UK). duced by ultraviolet C and gamma radiation. Duration of JNK activa-
tion may determine cell death and proliferation. J. Biol. Chem. 271,
Cytotoxicity Assays 31929±31936.
The cytocidal activity of tested agents was determined as described
Chinnaiyan, A.M., O'Rourke, K., Yu, G.L., Lyons, R.H., Garg, M.,
(Wallach, 1984). Briefly, 12 hr prior to assay cells were seeded in Duan, D.R., Xing, L., Gentz, R., Ni, J., and Dixit, V.M. (1996). Signal
96-well plates at a density of 2.5 3 104 cells/well. Human recombi- transduction by DR3, a death domain-containing receptor related
nant TNF and mouse recombinant TNF (Genentech, South San Fran- to TNFR-1 and CD95. Science 274, 990±992.
cisco, CA), the Jo2 anti-Fas/Apo1 monoclonal antibody, and the
Conlon, R.A., and Herrmann, B.G. (1992). Detection of messengermouse anti-p55 TNF receptor monoclonal antibodies 18 and 20, at
RNA by in situ hybridization to post implantation embryo wholea 1 to 1 ratio (Engelmann et al., 1990), were applied to the cells in
mounts. Methods Enzymol. 225, 361±372.the presence of cycloheximide (50 mg/ml). Ceramide (C6-D-erythro-
Duan, H., and Dixit, V.M. (1997). RAIDD is a new ªdeathº adapterceramide; Matreya, PA), etoposide (Sigma), staurosporine (Sigma),
molecule. Nature 385, 86±89.VSV (Indiana strain, ATCC VR-158 grown on WISH cells), and UV-C
treatment were applied to the cells in the absence of cycloheximide. Engelmann, H., Holtmann, H., Brakebusch, C., Shemer Avni, Y.,
After treatment for 12 hr (for TNF, anti-Fas, anti-CD120a,and stauro- Sarov, I., Nophar, Y., Hadas, E., Leitner, O., and Wallach, D. (1990).
Antibodies to a soluble form of a tumor necrosis factor receptorsporine) or 24 hr (for all others), cell viability was assessed by mea-
have TNF-like activity. J. Biol. Chem. 265, 14497±14504.suring the uptake of the dye neutral red (Finter, 1969).
To assess the death resulting from serum deprivation, cells were Fernandes-Alnemri, T., Armstrong, R.C., Krebs, J., Srinivasula, S.M.,
washed three times with phosphate-buffered saline and then incu- Wang, L., Bullrich, F., Fritz, L.C., Trapani, J.A., Tomaselli, K.J., Lit-
bated for 48 hr with DMEM supplemented with various FCS concen- wack, G., and Alnemri, E.S. (1996). In vitro activation of CPP32
trations. and Mch3 by Mch4, a novel human apoptotic cysteine protease
containig two FADD-like domains. Proc. Natl. Acad. Sci. USA 93,
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